- Report
- March 2025
- 142 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- January 2026
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 246 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- August 2025
- 180 Pages
Global
From €2100EUR$2,398USD£1,822GBP
€4200EUR$4,795USD£3,645GBP
- Report
- August 2025
- 80 Pages
United States
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
China
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
France
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
Germany
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
India
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
Saudi Arabia
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
South Korea
From €2273EUR$2,595USD£1,973GBP
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
United Kingdom
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 100 Pages
Africa
From €3324EUR$3,795USD£2,885GBP
- Report
- August 2025
- 100 Pages
Global
From €3324EUR$3,795USD£2,885GBP
- Report
- August 2025
- 100 Pages
Africa, Middle East
From €3324EUR$3,795USD£2,885GBP
- Report
- August 2025
- 80 Pages
Argentina
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
Brazil
From €2273EUR$2,595USD£1,973GBP
- Report
- August 2025
- 80 Pages
Ireland
From €2273EUR$2,595USD£1,973GBP

Ulipristal Acetate (UPA) is a medication used in the field of Sexual and Reproductive Health (SRH). It is a selective progesterone receptor modulator (SPRM) used for emergency contraception and for the treatment of uterine fibroids. UPA is a safe and effective option for women seeking emergency contraception, as it is more effective than other methods and can be taken up to five days after unprotected intercourse. It is also used to treat symptomatic uterine fibroids, as it can reduce the size of the fibroids and reduce associated symptoms.
UPA is available in many countries, including the United States, Canada, and the European Union. It is available in both generic and branded forms, and is typically sold as a single-dose tablet.
Some companies in the UPA market include HRA Pharma, Teva Pharmaceuticals, and Mylan. Show Less Read more